High-flow nasal cannula oxygen therapy versus conventional oxygen therapy in patients after planned extubation: a systematic review and meta-analysis.
Youfeng ZhuHaiyan YinRui ZhangXiaoling YeJianrui WeiPublished in: Critical care (London, England) (2019)
Our meta-analysis demonstrated that compared with COT, HFNC may significantly reduce postextubation respiratory failure and respiratory rates, increase PaO2, and be safely administered in patients after planned extubation. Further large-scale, multicenter studies are needed to confirm our results.
Keyphrases
- respiratory failure
- mechanical ventilation
- extracorporeal membrane oxygenation
- systematic review
- end stage renal disease
- newly diagnosed
- ejection fraction
- cardiac surgery
- chronic kidney disease
- case control
- acute respiratory distress syndrome
- prognostic factors
- stem cells
- intensive care unit
- randomized controlled trial
- meta analyses
- cross sectional
- clinical trial
- bone marrow
- mesenchymal stem cells
- double blind
- acute kidney injury